Exosome Diagnostic and Therapeutic Market Overview:
Exosome Diagnostic and Therapeutic Market was valued at $39 million, and is expected to reach $367 million by 2022, supported by a CAGR of 37.8%. Exosomes play a key role in facilitating cellto-cell communication in the cancer prognosis. Exosomes suppresses the immune function by inducing apoptosis of activated cytotoxic T cells, which enable tumor progression in the human body. In addition, exosomes also stimulate the angiogenesis and migration leading to metastasis. Moreover, exosomes trigger apoptosis in anti-tumor immune cells through tumor necrosis factor pathways. Furthermore, healthcare professionals use exosomes to diagnose cancer, which helps in profiling genetic changes in tumors and also prevent the spread of the disease.
APPLICATIONS OF EXOSOMES
This report covers information on various types of exosome products such as instruments, reagents, and software that are manufactured for medical and research purposes in compliance with the European Medical Association (EMA), the U.S. Food and Drugs Administration (FDA), Conformit Europene (CE) and other regulatory authorities. Moreover, this study on the global exosome diagnostic and therapeutic market also focuses on the application and end users of the market. By application, the market is segmented into diagnostic and therapeutic applications. Based on end user, the market is categorized into cancer institute, hospital, diagnostic centers, and others.
In accordance to several interviews conducted, the utilization of exosome isolation instrument is expected to witness a significant rise with increasing focus on life science research, rise in diagnostic procedures for cancer, and innovative and advanced applications of isolation kits.
The exosome diagnostic and therapeutic market is the point of interest in the liquid biopsy market as it is one of the emerging biomarker based procedures for the diagnosis of cancer. Moreover, remarkable technological advancements in the exosome isolation kits and reagents to provide advanced extraction procedures from the body fluids.
According to the experts from leading companies in operating in this market, increase in prevalence of cancer, technological advancements, and rising emphasis on early diagnosis of cancer are some of the major factors driving market growth. However, lack of awareness and stringent regulations for the approval of products used in exosome-based research hamper the growth of the market
Top impacting factors
Increase in prevalence of cancer; growth in initiatives implemented by the government and non-government associations for rise in health awareness; technological advancements in exosomes isolation and analytical procedures; and innovative and advanced applications of exosomes are the major factors that drive the growth of the exosome diagnostic and therapeutic market.
However, stringent government regulations for the approval of exosomes diagnostic and therapeutic products and low awareness about the applications of exosomes restrict the market growth. Furthermore, developing countries, such as China and India, provide huge growth opportunities to this market.
TOP IMPACTING FACTORS: WORLD EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET
Increasing prevalence of cancer across the world
Exosomes are nano vesicles that comprise proteins, DNA and RNA, with huge potential in the diagnosis of cancer. Increase in prevalence of cancer play an important role in the growth of the exosome diagnostic and therapeutic market.
For instance, according to Centers for Disease Control and Prevention (CDC), in 2012, 8.2 million cancer-related deaths were reported around the world and are expected to reach 19.3 million by 2025.
NUMBER OF CANCER PATIENTS IN MAJOR COUNTRIES, 2012 (AGE- STANDARDISED RATE PER 100,000)
The leading market players in the exosome diagnostic and therapeutic market focus to expand their business operations in the emerging countries. The companies operating in the market have consistently introduced innovative solutions to enhance their product portfolio. Product launch and partnerships are observed as the two prominent growth strategies adopted by the key market players. The major players profiled in this report include Aethlon Medical, Inc. (U.S.), Exosome Diagnostics Inc. (U.S.), NanoSomix Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Malvern Instruments Ltd. (U.K,), System Biosciences Inc. (U.S.), NX Pharmagen (U.S.), Sistemic Inc. (U.K.), Capricor Therapeutics (U.S.), and Exiqon A/S (Denmark).
Other players in the value chain include 101BIO, AMS Biotechnology Limited, Therapeutic Solutions International, Inc., ReNeuron Group plc, Immune Therapy Holdings AB, ExoCyte Therapeutics Pte Ltd , Cell Guidance Systems LLC, BioRegenerative Sciences, Inc., Evomic Science LLC, and Norgen Biotek Corp.
Key benefits of Exosome diagnostic and therapeutic market
- The study provides an in-depth analysis of the exosome diagnostic and therapeutic market, with current trends and future estimations to elucidate the imminent investment pockets.
- The report provides a quantitative analysis from 2014 to 2022 to enable the stakeholders to capitalize on prevailing market opportunities.
- Extensive market analysis by product assist in the treatment of various chronic and infectious diseases such as cancer, cardiovascular diseases, and other diseases.
- Competitive intelligence highlights the business practices followed by leading market players across various geographic regions.
- Key market players are profiled and their strategies are analyzed thoroughly, which predicts the competitive outlook of the market.
EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET KEY SEGMENT
BY END USER
Rest of Europe
Rest of Asia-Pacific